ResearcherChang Gung UniversityNo recent work listed
Pei‐Wei Huang
Matched on ORCID iD 0000-0001-6591-0783; OpenAlex author ID A5089593550. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 3 papers
Papers 3
- Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy. Co-author DOI 10.1002/cam4.2483↗
- Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model. First author DOI 10.3390/cancers11010057↗
- Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. Co-author DOI 10.3390/jcm8091402↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yu‐Shin Hung · 3 shared papers, 2019 · strength 0.28
- Paper Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Develop… DOI 10.3390/cancers11010057↗
- Paper Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chem… DOI 10.1002/cam4.2483↗
- Paper Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. DOI 10.3390/jcm8091402↗
- Wen‐Chi Chou · 3 shared papers, 2019 · strength 0.28
- Paper Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Develop… DOI 10.3390/cancers11010057↗
- Paper Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chem… DOI 10.1002/cam4.2483↗
- Paper Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. DOI 10.3390/jcm8091402↗
- Pei‐Hung Chang · 3 shared papers, 2019 · strength 0.28
- Paper Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Develop… DOI 10.3390/cancers11010057↗
- Paper Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chem… DOI 10.1002/cam4.2483↗
- Paper Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. DOI 10.3390/jcm8091402↗
- Ching‐Fu Chang · 2 shared papers, 2019 · strength 0.19
- Paper Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Develop… DOI 10.3390/cancers11010057↗
- Paper Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chem… DOI 10.1002/cam4.2483↗
- Yen‐Yang Chen · 2 shared papers, 2019 · strength 0.19
- Paper Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Develop… DOI 10.3390/cancers11010057↗
- Paper Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chem… DOI 10.1002/cam4.2483↗
- Jen‐Shi Chen · 2 shared papers, 2019 · strength 0.19
- Paper Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Develop… DOI 10.3390/cancers11010057↗
- Paper Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chem… DOI 10.1002/cam4.2483↗
- Keng-Hao Liu · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.